Close Menu
Keep Up with USA Daily Hunt UpdatesKeep Up with USA Daily Hunt Updates
  • Home
  • USA
  • World
  • Business
    • CEO
    • Realtor
    • Founder
    • Entrepreneur
    • Journalist
  • Health
    • Doctor
    • Plastic surgeon
    • Beauty cosmetics
  • Sports
    • Athlete
    • Coach
    • Fitness trainer
    • Entertainment
  • Finance
  • Politics
  • Science
Sunday, July 20
Trending
  • Presidential Privilege: The Fall of an American Dynasty
  • Heart attacks are no longer the leading cause of death in the US
  • Donald Trump with Nato ‘all the way’ after questioning mutual defence pact
  • U.S. and Israeli Triumphalism Against Iran Is Premature
  • Skincare 101: Start Here – ThisThatBeauty
  • RECELL for Acute Wound Care and Reconstruction
  • Mount Waverley luxe designer home hits market
  • Hyderabad-based data sharing platform Equal figures in WEF list
Keep Up with USA Daily Hunt UpdatesKeep Up with USA Daily Hunt Updates
  • Home
  • USA
  • World
  • Business
    • CEO
    • Realtor
    • Founder
    • Entrepreneur
    • Journalist
  • Health
    • Doctor
    • Plastic surgeon
    • Beauty cosmetics
  • Sports
    • Athlete
    • Coach
    • Fitness trainer
    • Entertainment
  • Finance
  • Politics
  • Science
Keep Up with USA Daily Hunt UpdatesKeep Up with USA Daily Hunt Updates
Home » News » Daily pill could replace weight-loss shots like Ozempic and Wegovy
Science

Daily pill could replace weight-loss shots like Ozempic and Wegovy

Daniel PetersonBy Daniel Peterson Science
Share
Facebook Twitter LinkedIn Pinterest Email

Can medications to lose weight in needles?

Aleksandr Zubkov/Getty Images

A daily pill seems to reduce blood sugar in people with type 2 diabetes as effective as injectable medications such as Ozempic and Mounjaro. The medicine, called Orforglipron, also led to a substantial loss of weight in clinical trials, which means that Bemacome could a convenient alternative to popular medicines for weight loss.

The drugs that mimic the GLP-1 hormone, which regulates appetite and blood sugar, have exploited in popularity. Known as GLP-1 agonists, these medications can treat obesity, type 2 diabetes and heart disease. An inconvenience is that almost …

]

Previous ArticlePerfios acquires IHX to strengthen healthcare information insurance
Next Article Your daily MLB trivia game, Monday edition

Related Posts

Heart attacks are no longer the leading cause of death in the US

June 25, 2025

Sea spiders ‘farm’ methane-eating bacteria on their bodies

June 22, 2025

Innovation Under the Microscope: How Dr. Leo Grant’s Lab Is Leading America’s Breakthroughs in Genetic Medicine

June 21, 2025
Top Posts

Presidential Privilege: The Fall of an American Dynasty

July 14, 2025

Heart attacks are no longer the leading cause of death in the US

June 25, 2025

Donald Trump with Nato ‘all the way’ after questioning mutual defence pact

June 25, 2025

U.S. and Israeli Triumphalism Against Iran Is Premature

June 25, 2025

Skincare 101: Start Here – ThisThatBeauty

June 25, 2025

RECELL for Acute Wound Care and Reconstruction

June 25, 2025

Discover breaking news, trends, and expert insight every day. Politics, economics, entertainment, and more are covered live by USA Daily Hunt. Receive daily updates on the world's most significant happenings
We're social. Connect with us:

  • Sports
  • Athlete
  • Coach
  • Health
  • Beauty cosmetics
  • Fitness trainer
  • Doctor
  • Plastic surgeon
  • USA
  • World
  • Finance
  • Politics
  • Science
  • Business
  • CEO
  • Founder
  • Journalist
  • Realtor
  • Entrepreneur
© 2017-2025 USA Daily Hunt. All Rights Reserved.
  • USA
  • World
  • Finance
  • Politics
  • Science

Type above and press Enter to search. Press Esc to cancel.